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ABSTRACT 
In this thesis, I present a lab-on-a-chip (LOC) that can separate and 
detect Escherichia Coli (E. coli) in simulated urine samples for Urinary 
Tract Infection (UTI) diagnosis. The LOC consists of two (concentration 
and sensing) chambers connected in series and an integrated impedance 
detector. The two-chamber approach is designed to reduce the non-
specific absorption of proteins, e.g. albumin, that potentially co-exist with E. 
coli in urine. I directly separate E. coli K-12 from a urine cocktail in a 
concentration chamber containing micro-sized magnetic beads (5 µm in 
diameter) conjugated with anti-E. coli antibodies. The immobilized E. coli 
are transferred to a sensing chamber for the impedance measurement. 
The measurement at the concentration chamber suffers from non-specific 
absorption of albumin on the gold electrode, which may lead to a false 
positive response. By contrast, the measured impedance at the sensing 
chamber shows ~60 kΩ impedance change between 6.4x104 and 6.4x105 
CFU/mL, covering the threshold of UTI (105 CFU/mL). The sensitivity of 
the LOC for detecting E. coli is characterized to be at least 3.4x104 
CFU/mL. I also characterized the LOC for different age groups and white 
blood cell spiked samples. These preliminary data show promising 
potential for application in portable LOC devices for UTI detection. 
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1. INTRODUCTION 
1.1…..Introduction 
Human urine is commonly used in regular medical check-ups and 
tests to identify the cause of symptoms [1]. Urine is a rich source for 
evaluating overall health, especially kidney function, for instance, because 
urine contains hundreds of body wastes that kidneys filter from the blood. 
Urinary Tract Infections (UTI) are common kidney-related diseases in 
humans, especially women. They account for 8 million hospital visits 
annually in the US [2]. Moreover, UTI has a high recurrence rate: among 
individuals of a first infection, 20% has their second infection within six 
months, and 3% has a third infection within six months [3],[4]. Escherichia 
Coli (E. coli) is responsible for up to 80% of UTI [5],[6], and conventional 
detection methods, bacteria culture for a urine sample require 24 to 48 
hours cultivation and labor-intensive procedures [7]. Being able to rapidly 
identify living cells without culturing is very important to medical diagnosis 
and treatment because microorganisms can cause severe diseases [8],[9], 
and some progress very quickly [10],[11]. Though more rapid test methods 
do exist, such as the dip-stick method for E. coli detection, and such 
method is based on nitrite and esterase and offers fast detection, but does 
not provide sufficient sensitivity [12]. 
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1.2…..Background 
Immunomagnetic separation (IMS) [13],[14] and impedance 
spectrometry (IS) techniques have been frequently used to capture and 
detect E. coli [33]. Some have been implemented in a miniaturized form of 
detector [33]. These IMS/IS techniques presented focus on detecting E. 
coli O157, which are a cause of foodborne illness [15]. Wright et al. used 
IMS to collect and detect E. coli O157 from minced beef samples. They 
used magnetic beads coated with anti-E. coli antibodies to isolate E. coli 
O157 from the beef samples and cultured them to count colony forming 
unit (CFU) [13]. Perez et al. presented IMS to capture E. coli O157 and 
detected them electrochemically [14]. They also measured a calibration 
curve of CFU, mapped to the electrochemical response. Besides these 
work there are a number of prior work using IMS/IS techniques to collect 
and detect E. coli [16],[17],[18]. Varshney et al. used magnetic 
nanoparticles conjugated antibody for detection E. coli O157 in food 
samples [33]. The nanoparticles immobilized biotin-labeled polyclonal goat 
anti-E. coli antibodies to separate and concentrate E. coli O157:H7 from 
ground beef samples. Then, the impedance of the cluster of the 
nanoparticles and E. coli were measured using interdigitated 
microelectrodes. The lowest detection limits of their biosensor in pure 
culture and ground beef samples were 7.4 x 104 and 8.0 x 105 CFU/mL. 
By miniaturizing electrodes and using nanoparticles, the sensitivity 
enhances and the flexibility of electrode fabrication improves. Miniaturized 
3 
electrodes also allows to perform IS in low conductivity solution since they 
require lower concentrations of electro-active ions to form double layer as 
compared to macrosized counterparts. An excellent review on 
miniaturized impedance biosensors for detecting bacteria is available in 
[32]. 
In this thesis, a lab-on-a-chip (LOC) is presented to separate E. coli 
and measure its concentration using magnetic beads (MBs) directly from a 
cocktail urine sample. The E. coli captured by MBs was evaluated by IS, 
and those IS measurements were further evaluated using the current 
standard practice of counting cultured CFUs. An E. coli concentration of 
105 CFU/mL or higher in urine is typically considered a UTI, and several 
different E. coli serotypes can cause UTI [23],[24],[25]: O1 : K1 : H7, O6 : 
K15 : H31 ; SmR, O6 : K2 : H1, O18 : K1 : H7 ; SmR, and O4 : K6 ; NalR. 
Since UTI-related E. coli demands high safety requirements, E. coli K-12 
was used instead of serotypes such as O1 : K1 : H7 and O6 : K15 : H31 ; 
SmR. Normal urine does not contain any protein, or contains only trace 
amounts of it [26],[27]. For UTI patients, however, albumin may be 
excreted and contained in the urine. I attempted to make the closest 
possible simulation of UTI-infected urine sample by spiking albumin and E. 
coli K-12 in cocktail urine. The LOC was also characterized using the 
simulated urine having different concentrations of E. coli, co-existing with 
while blood cells (WBCs).  
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1-3…..Motivation 
Significant research efforts have focused on shortening analysis 
time, and on detecting E. coli with increasing sensitivity and high accuracy. 
One example is the work performed by Klodzinska et al., who separated E. 
coli using Capillary Zone Electrophoresis (CZE) and the presence of 
negatively charged ions of carboxyl and phosphate groups on the bacterial 
cell wall [19]. The capillary surface was modified to separate E. coli, and 
spectrophotometry measured the concentration of bacterial cells. The high 
voltage (20kV) supply used in the work, however, could cause 
electromagnetic interference, posing a bottleneck in the development of a 
portable hand-held unit for use at a patient’s bedside [20],[21]. In another 
example, Ruan et al. immobilized anti-E. coli antibodies on a planar 
electrode to detect E. coli O157:H7 [22]. The surface of glass electrodes 
coated by indium tin oxide were modified and detected E. coli, but the 
capturing rate was low; this may lead false-negative results under the 
normal use. I believe that microfluidics in IMS may overcome such 
limitations. Despite of such success of many microsized platforms, few 
study have focused on detecting bacteria in urine for UTI applications. 
This motivates developing a micro-chip to integrated IMS/IS to detect E. 
coli for UTI applications. 
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1-4…..Thesis Outline 
 This thesis is organized as follows. The design analysis of device, 
fabrication method and experimental methodology are presented in 
chapter 2. Chapter 3 describes the procedure of preparation for 
experiment, and experimental result. Finally, conclusion is expressed in 
chapter 4. 
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2. PROPOSED METHODOLOGY 
 In this chapter, device design, fabrication and experiment 
methodology are described in detail. The design analysis is presented in 
section 2-1. Section 2-2 presents a method to fabricate the device. The 
experimental methodology is presented in section 2-3. 
2-1…..Design 
The design of the E. coli separator is illustrated in Fig. 2-1. Two 
chambers, one for concentration and the other for sensing, are connected 
in series with two mechanical valves [28] to control the fluidic stream. The 
dimension of the chambers and inlets is 1.8 × 3.0 × 0.05 mm3 (W×L×H), 
and that of the microfluidic channels is 0.5 × 5.0 × 0.05 mm3 (W×L×H). 
The two gold electrodes for IS measurement are 1.0 × 1.5 mm2 (W×L), 
and these are placed in the concentration and sensing chambers. MBs are 
retained and transported inside and between the chambers using two 
permanent magnets (K&J Magnetic, Inc.) placed above and beneath the 
chambers. 
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Figure 2-1: Schematic of the E. coli separator lab-on-a-chip (LOC) 
integrated with on-chip impedance spectrometry (IS) for UTI applications. 
 
2-2…..Fabrication 
I used the Replica-Molding (REM) technique, which transfers 
surface patterns on a mold to an elastomeric material. A silicon substrate 
and PDMS were used for the mold and elastomeric material, respectively. 
The fabrication of the silicon mold is shown in Fig. 2-2 requiring two-mask 
process using AZ 4330 photoresist and one Deep-RIE (Reactive Ion 
Etching), 50 μm deep, step. 
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Figure 2-2: Fabrication process flow of the LOC E. coli separator 
integrated with on-chip IS. 
 
Once the silicon mold was fabricated, PDMS was prepared by 
mixing silicone elastomer and curing agent in a 10:1 ratio and pouring it on 
the mold. After curing, the PDMS replicate was peeled off and assembled; 
two screws were mounted and used for mechanical valves. The gold 
electrodes, chrome/gold (10 nm/200 nm), were lithographically patterned 
on the glass slide. The glass slide and PDMS replicate were treated by 
oxygen plasma (Harrick Plasma) for 1 min at 100 W, and bonded, then 
cured for 20 min at 80 °C in the oven. The fabricated LOC is shown in Fig. 
2-3. 
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Figure 2-3: Fabricated LOC E. coli separator integrated with on-
chip IS 
 
2-3….. Methodology 
MBs were conjugated with anti-E. coli antibodies. First, 400 mM of 
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) and 
100 mM of N-hydroxylsulfosuccinimide (NHS) were freshly prepared in DI 
(de-ionized) water and mixed with MBs to activate COOH-terminated self-
assembled monolayers (SAMs). After 15 min of incubation, the mixture of 
MBs with NHS and EDC was washed with PBS solution. The anti-E. coli 
antibody was prepared with 10 mM NaAc (sodium acetate), pH 5.3 
solution, and the anti-E. coli antibody and NaAc mixture was mixed with 
MBs to conjugate with activated COOH-terminated SAM on the surface of 
the MBs. After completing the antibody bonding to the COOH-terminated 
SAM, the unbound, activated COOH-terminated SAM was blocked by 
ethanolamine [29],[30]. 
There are several example of prior art that modeled the equivalent 
circuit of E. coli on thin film electrodes and E. coli conjugated with 
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magnetic particles [33]. Radke et al. modeled E. coli O157:H7 on 
interdigitated electrodes [31]. The equivalent model of E. coli consists of 
the resistance of the cytoplasm, the resistance of the cell membrane, and 
the capacitance of the cell membrane. Additionally, the parasitic 
capacitance includes the double-layer capacitance at the electrode 
surface and stray capacitance associated with the oxide layer sandwiched 
between the gold electrodes and silicon. Varshney et al. presented an 
equivalent circuit model of magnetic nanoparticles attached to E. coli on a 
thin film electrode [33]. The model consists of double layer capacitance, 
stray capacitance (associated with electrodes, shielding, wires, cables, 
and adhesives), and resistance of medium or bulk that represents the 
cluster of magnetic nanoparticles and E. coli. The equivalent model was 
characterized by a series of measurements, which fit very well to the 
model. It is very difficult to model the undefined number of magnetic 
particles and E. coli clusters between sensing electrodes. One cannot 
assume a distributed model of a cluster of a magnetic particle and E. coli 
since non-uniform electric field density exists inside the chamber. 
A non-Faradaic equivalent circuit is used to model IS 
measurements of the LOC as shown in Fig. 2-4. The equivalent circuit 
consists of two double layer capacitances (Cdl), connected in series with a 
bulk medium resistor (Rs), and a stray capacitor (Cs) connected in parallel 
with Cdl and Rs [32],[33]. Cdl comes from the effect of ionic species near 
the electrode surface. Rs reflects the conductivity change in bulk medium 
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and charge transport across the bulk solution. Cs represents stray 
capacitance associated with shielding, electrodes, and the adhesion layer 
between the gold electrode and glass. Contributions to the total 
impedance value can be expressed by the equations below: 
Z1  Rs
2 
1
(fCdl )
2 , Z2 
1
(2fCs)
2 , 
1
Ztotal

1
Z1

1
Z2
   (1) 
where f is frequency, Z1 is the impedance of Rs and Cdl, Z2 is the 
impedance of Cs, and Ztotal is the total impedance of Z1 and Z2. The current 
cannot pass through Cs at low frequency; this results in an open circuit, 
and only the Cdl and Rs path is active and contributes to total impedance. 
At high frequency, however, current passes through Cs, and Rs and Cdl 
can be ignored. 
 
Figure 2-4: Equivalent circuit model for the IS. 
  
RsCdl Cdl
Cs
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3. EXPERIMENTAL RESULTS 
 In this chapter, the experiment procedure and result are presented. 
Section 3-1 reports what reagent and analyte are used for experiments. 
Then test procedure and test set-up are described in section 3-2. In 
section 3-3, capture efficiency is presented and the experiment results are 
reported in section 3-4. 
3-1…..Reagent and analyte 
Affinity-purified rabbit anti-E. coli antibody (1.0 mL, 4.6 mg/mL) was 
purchased from ViroStat (Portland, ME) and diluted with PBS (0.01 M, pH 
7.4) from Fisher Scientific. MBs from Spherotech, Inc. were 4.5 μm in 
diameter and coated by COOH-terminated SAMs on the surface. The 
activating reagents that couple anti-E. coli antibody to the COOH-
terminated SAMs on the MB are EDC and NHS, as purchased from 
Pierce. NaAc was obtained from Mediatech, Inc. Ethanolamin from Sigma 
was used as a blocking buffer. One tenth molar solution of mannitol 
(Sigma-Aldrich) in DI water from Millipore (Milli-Q, 18.2MΩcm) was used 
for washing and IS measurement. Simulated urine cocktail was prepared 
by mixing ingredient A and B (Table 3-1) in 1 L of sterilized DI water. E. 
coli K-12 (ATCC 10798) was obtained from American Type Culture 
Collection (Rockville, MD). The pure culture of E. coli K-12 was prepared 
in tryptic soy broth (BD, Franklin Lakes, NJ) at 37°C for 24 h. Pure 
cultures were serially diluted in PBS and surface plated on nutrient agar 
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plate (PML Microbiologicals), incubated at 37°C for 20 to 24 h, to check 
CFUs at different concentrations. 
Table 3-1. 
Simulated urine cocktail composition. 
Ingredient A 
CaCl2.H2O 1.77g 
Na2SO4 4.86g 
MgSO4.7H2O 1.46g 
NH4Cl 4.6g 
KCl 12.13g 
Urea 25g 
Creatinine 1.1g 
tryptic soy (0.25-0.5%) 5 or 2.5g 
 
Ingredient B 
NaH2PO4.2H2O 2.66g 
Na2HPO4 0.87g 
NaCitrate 1.17g 
NaCl 13.545g 
Urea 25g 
Creatinine 1.1g 
tryptic soy (0.25-0.5%) 5 or 2.5g 
 
3-2…..Test procedure and test setup 
Fig. 3-1 illustrates the test setup of the fabricated LOC E. coli 
separator/sensor. Three different syringe pumps contain MBs with anti-E. 
coli antibody, mannitol solution, and E. coli K-12 in cocktail urine, and 
deliver them to a six-way valve. An LCR meter (Agilent E4908A) 
measured from 10 Hz to 1 MHz at the concentration and sensing 
chambers.  
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Figure 3-1: Schematic of characterizing the fabricated LOC E. coli 
separator integrated with on-chip IS. 
 
Fig. 3-2 depicts the test procedure. First, when valve-2 closed, 
mannitol solution flew into the separator at 10 μL/min; MBs with anti-E. coli 
antibody were inserted as shown in Fig. 5(a). The mannitol solution was 
used to allow E. coli to live and enable impedance measurement as it has 
high impedance. Two permanent magnets were placed on the top and 
bottom of the concentration chamber and retained the MBs, which were 
then washed by mannitol solution for 30 min at 10 μL/min. 5 μL of cocktail 
urine containing different concentrations of E. coli K-12 and albumin were 
injected through the chip. Once MBs captured E. coli K-12 in the cocktail 
urine, mannitol solution again flew to wash the concentration chamber for 
30 min at 10 μL/min, and then IS was performed using a LCR meter 
(E4980A Precision LCR Meter from Agilent Inc.). When valve-1 closed 
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and valve-2 opened, the two permanent magnets above and beneath the 
concentration chamber were relocated at the sensing chamber as shown 
in Fig. 5(b). Mannitol solution then transported MBs with E. coli K-12 from 
the concentration to sensing chamber at 10 μL/min. Then, the impedance 
was measured. Both electrodes pairs in the concentration and sensing 
chambers were used as they were without any surface modification. At the 
end of each measurement, the E. coli separator was washed with 0.1 M 
sodium hydroxide for 30 min, DI water for 30 min, 0.1 M hydrochloric acid 
for 30 min, and DI water for 30 min. 
 
Figure 3-2: Test procedure: (a) MBs retention, direct E. coli 
separation from cocktail urine, and IS measurement in the concentration 
chamber and (b) MBs’ transfer and retention and IS measurement in the 
sensing chamber. 
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Table 3-2 shows the step-by-step procedure of the microchip 
operation and associated time to complete each step. The total analysis 
time is roughly 100 mins. Please note that this does not include fabricating 
microchips and immobilizing MBs with anti-E. coli antibodies. I assume 
these steps are performed before the analysis. I used mannitol solution to 
rinse microfluidic channels and chambers. The rinsing step is to ensure I 
remove all unnecessary entities to enhance sensitivity of the microchip. 
Table 3-2 
Step-by-step procedure and required time  
 
3-3…..Capture efficiency 
One of biggest advantage of using IMS is in capture efficiency (CE). 
Prior art using IMS reported up to 100% CE [33],[34]. I characterized CE 
in a single chamber configuration using a standard fluorescent intensity 
Step 
# 
Description Time 
[min] 
1 Preparation of E. coli sample 5 
2 Capture the MBs using two permanent magnets in 
the concentration chamber 
10 
3 Flow manitol solution to rinse the microfluidic 
channels/chambers 
30 
4 Flow E. coli sample 5 
5 Flow manitol solution to rinse the microfluidic 
channels/chambers 
30 
6 Perform impedance spectroscopy measurements at 
the concentration chamber 
5 
7 Move and immobilize E.coli-conjugated MBs inside 
the sensing chamber 
10 
8 Perform impedance spectroscopy measurements at 
the sensing chamber 
5 
 Total time required to complete the procedure 100 mins 
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measurement. MBs having anti-E. coli antibodies were placed inside the 
chamber and held by permanent magnets on the top and bottom of the 
chamber. After packing the chamber I flew 3 μL of 107 E. coli/mL that were 
conjugated with red fluorescent dye and chemically dialyzed (E-2863, 
Invitrogen Inc.). Then, the permanent magnets were removed, and MBs 
were collected with E. coli at the outlet. The fluorescent intensity was 
measured using an inverted microscope. The measured fluorescent 
intensities were compared to that of E. coli before being captured by MBs. 
It was repeated the experiments for a different length of the column from 1 
to 6 mm as shown in Fig. 6. As the column length increased, CE improved; 
however the applied fluidic pressure also increased. At the length of 3.2 
mm, the fluidic pressure reaches 100 psi, structural failure point, based 
upon the geometry. This determined the channel length as 3 mm. 
 
Figure 3-3: Capture efficiency (CE) of the E. coli separator as a 
function of the concentrator length. 
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3-4…..Results 
Fig. 3-4 shows the bode plot and phase angle of the IS 
measurement and fitted impedance spectra for 6.4 x 108 CFU/mL of E. coli 
K-12 attached to the antibody of the MBs retained in the sensing chamber. 
The fitting was generated by ZSimp software [35],[36]; mean errors of 
impedance and phase angle shown in Table 3-3 were 6% and 0.8°, 
respectively. Based on the phase angle, there are two distinct regions in 
the impedance spectra, which correspond to two elements in the 
equivalent circuit. The double layer capacitance can be measured below 
10 Hz; however I was not able to measure it because the LCR meter 
cannot measure below 10 Hz. When the frequency is between 10 Hz and 
10 kHz, current cannot pass through Cs, resulting in an open circuit in the 
equivalent circuit; only the Cdl and Rs become active, but Rs is more 
dominant because captured E. coli membrane becomes an insulator that 
increases the impedance [32],[37]. By contrast, Cdl and Rs become 
inactive at higher frequencies (above 10 kHz); the E. coli membrane 
becomes electrically invisible and the value of Cdl is larger than Cs, 
contributing all the impedance change at a frequency above 10 kHz. 
19 
 
 
Figure 3-4: IS measurement of 6.4×108 CFU/mL E. coli. 
Table 3-3. 
Measured and fitted values of each component in IS equivalent circuit. 
 Measured Fitted Error 
Rs 1.68 MΩ 1.68MΩ 0.3% 
Cs 3.8 pF 3.9 pF 0.1% 
 
I spiked E. coli K-12 and albumin in urine cocktail and repeated the 
separation/detection procedure in the concentration chamber (Fig. 3-5(a)). 
Large impedance change was observed between high E. coli 
concentrations (6.4 x 108 CFU/mL and 6.4 x 107 CFU/mL), and the control 
(MBs with anti-E. coli antibody). On the other hand, low E. coli 
concentrations (6.4 x 105 CFU/mL and 6.4 x 104 CFU/mL) showed almost 
no impedance change. I believe this is due to the masking effect of 
albumin; albumin absorbed on the electrodes, thus low concentration E. 
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coli cannot be well discriminated. Moreover, impedance changes between 
the low concentration samples and the control are very large. The 
changes may cause a false-positive response. The albumin in the urine 
cocktail was absorbed on the gold electrode by hydrophobic interaction in 
the concentration chamber [38],[39]. In the higher E. coli concentration, E. 
coli was the dominant factor to increase Rs, medium resistance, but in the 
lower concentration, albumin absorbed on the gold surface resulted in 
constant impedance change. 
Fig. 3-5(b) shows the IS measurement in the sensing chamber 
where MBs conjugated with E. coli were transported from the 
concentration chamber. Compared to the IS measurement in the 
concentration chamber, lower E. coli concentrations became clearly 
distinguishable in the sensing chamber. The impedance difference 
between 6.4 x 105 CFU/mL and 6.4 x 104 CFU/mL was approximately 60 
kΩ at 1 kHz.  
 
(a) 
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(b) 
Figure 3-5: IS measurement for different E. coli K-12 concentrations 
ranging from 6.4x104 to 6.4x108 CFU/mL in the concentration chamber (a) 
and the sensing chamber (b). 
 
Fig. 3-6 summaries the impedance change at 1 kHz in the sensing 
chamber. 60 kΩ resistance change was observed between the 6.4 × 104 
CFU/mL and 6.4 × 105 CFU/mL; the threshold of UTI is 105 CFU/mL 
[23],[24]. Therefore, the IS measurement suggests that the LOC 
separator/detector is capable of evaluating urine samples for UTI. 
 
Figure 3-6: Impedance spectrum of different E. coli concentrations 
at 1kHz in the sensing chamber. 
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Fig. 3-7 shows the sensitivity characterization of the LOC. I used 
the same simulated urine samples and spiked E. coli from 3.4 x 107 
CFU/mL down to 3.4 x 103 CFU/mL. Impedance spectrums at 1 kHz in 
both concentration and sensing chambers were measured and compared. 
The sensitivity, slope of the bars, in the concentration chamber is lower 
than that in the sensing chamber. Above 3.4 x 106 CFU/mL, the 
impedance increases significantly in both concentration and sensing 
chambers. The minimum detectable concentration of E. coli follows the 
similar trend. The data between 3.4 x 103 and 3.4 x 104 CFU/mL in the 
concentration chamber are indistinguishable while the data in the sensing 
chamber are clearly distinguishable. This suggests the minimum 
detectable concentration of E. coli of the LOC is at least 3.4 x 104 CFU/mL. 
However, below 3.4 x 104 CFU/mL, it is too close to the control (control 
has 112 kΩ and the concentration of 3.4 x 104 CFU/mL has 113 kΩ). The 
3.4 x 104 CFU/mL minimum detectable concentration is lower than the 
threshold of UTI (105 CFU/mL). 
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Figure 3-7: Sensitivity of the microfluidic device to detect E. coli (at 
1 kHz).  
 
WBC may present in urine. Having more than 10 WBCs/μL in urine 
is considered to be a high chance of UTI [40]. I spiked 35 cells/micro-L 
WBC (from Innovative Research, Inc.) in the simulated urine cocktail 
having 3.4 x 104, 3.4 x 105, and 3.4 x 106 CFU/mL E. Coli to see how 
WBC impacts the impedance measurements at concentration and sensing 
chambers, respectively as shown in Fig. 3-8. One can see a substantial 
gap of impedance measured between the control and the rest in the 
concentration chamber (Fig. 3-8(a)). Also the impedance measurements 
of three concentrations (3.4 x 104, 3.4 x 105, and 3.4 x 106 CFU/mL) 
overlap each other, which I believe it is due to the protein screening effect. 
On the other hand, the data in the sensing chamber (Fig. 3-8(b)) shows a 
different pattern; there is no abrupt change of the measured impedance as 
the concentration increases. The impedance is roughly proportional to the 
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E. coli concentration as shown in Fig. 3-8(c). It is clear to observe that the 
measurements in the sensing chamber offered more consistent results 
than the ones in the concentration chamber when the samples were 
spiked by WBC. 
  
(a) 
  
(b) 
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(c) 
Figure 3-8: Impedance spectrum of simulated urine samples having 
35 WBCs/micro-L in three different E. coli concentrations in the (a) 
concentration and (b) sensing chambers. (c) Impedance comparison of 
concentration/sensing chambers at 1 kHz 
 
Human urine can be very diverse such as volume per day and pH 
of different age/sex groups [41]. I attempted to compare impedance 
responses of three different urine cocktails as shown in Fig. 3-9: 20 yr-old, 
40 yr-old, and 60 yr-old female, respectively. I chose urine cocktails [41] 
for female only since up to 40% of women will develop UTI at least once 
during their lives [42]. The impedance measurements of the controls for 
three samples were largely different: 232 kΩ for 20 yr-old control, 135 kΩ 
for 40 yr-old control, and 799 kΩ for 60 yr-old control. This is partially 
because I used three different micro-chips. However it is notable that the 
impedance changes as a function of E. coli concentration showed different 
patterns from one from the other urine cocktails. The impedance of 40 yr-
old samples showed larger increase over that 20 yr- and 60 yr-old 
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samples. It is hard to draw a conclusive evidence of any fundamental 
mechanism that describes the discrepancy of the three groups of samples; 
yet the measurements strongly suggest that the presented micro-chip 
must be calibrated for diverse nature of urine samples. 
 
Figure 3-9: The effect of diversity on human urine compositions; 
comparison of measured impedance of 20 yr-old (blue), 40 yr-old (red), 
and 60 yr-old (green) female urine cocktails as a function of spiked E. coli 
concentration. 
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4. CONCLUSION 
4-1…..Summary 
In this thesis I present a micro-chip to study UTI using simulated 
urine samples. The target micro-organism to detect is E. coli which are 
responsible for 80 % of UTI. I designed a LOC which is equipped with dual 
chamber configuration that separates and measures the concentration of 
E. coli for UTI applications. MBs were conjugated with anti-E. coli antibody 
to capture E. coli and were transported from concentration to sensing 
chambers. The integrated electrodes allowed IS to measure the 
concentration of the captured E. coli. The IS measurements between 
concentration and sensing chambers showed that non-specific binding 
from albumin could cause a false-positive response. I believe that this 
result comes from a hydrophobic interaction between the gold electrodes 
in the concentration chamber and albumin in UTI-infected urine. The IS 
measurement in the sensing chamber showed a significant impedance 
change to evaluate UTI: ~60 kΩ, between 6.4 x 104 CFU/mL and 6.4 x 105 
CFU/mL. Sensitivity of the LOC was characterized to be at least 3.4 x 104 
CFU/mL, which is less than the threshold of UTI (105 CFU/mL). I also 
characterized the LOC for the interference of WBCs to impedance 
measurements and for different urine cocktail, and no significant 
interference and discrepancy were observed.  
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4-2…..Future works 
This preliminary results using E. coli K-12 may suggest that the 
LOC E. coli separator/sensor can be used to detect UTI E. coli in human 
urine. Before testing a target bacteria, UTI E. coli, however, I will need to 
optimize the capture rate of the E. coli separator and increase the 
sensitivity of IS measurements. 
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TABLE A-1  
Test procedure 
 
TABLE A-2 
Fabrication procedure 
Step Description 
1 MBs are mixed with EDC, NHS, acetate and antibody for 
immobilization of antibody on MBs 
2 Preparation of E.coli sample using cultured E. coli sample 
3 Capturing the MBs using permanent magnet on the 
concentration chamber 
4 Flow manitol solution using syringe pump by 10μL/min 
5 Flow E. coli sample using syringe pump by 1μL/min 
6 Flow manitol solution using syringe pump by 10μL/min 
7 Measure impedance change using LCR meter 
8 Moving and capturing MBs to sensing chamber by permanent 
magnet 
9 Measure impedance change using LCR meter 
Step Process 
1 Patterning Si wafer by AZ 4330 photoresist  
2 Hard bake photoresist for Deep RIE 
3 Deep RIE for 50um etching 
4 Removing photoresist by Acetone 
5 Mixing silicone elastomer with curing agent by 10:1 ratio for 
PDMS 
6 Molding PDMS on Si wafer 
7 Curing for 40 min in 120C̊ oven  
8 Peeling off on Si wafer 
9 Assembling two mechanical valves and one nanotube 
10 Cleaning glass slide by Acetone, Isopropyl-alcohol and DI water 
11 Pattering AZ4330 photoresist 
12 Depositing Cr/Au by 10nm/200nm by sputter 
13 Lift off Cr/Au by Acetone 
14 Cleaning surface of glass slide and PDMS by oxygen plasma 
for 1min. 
15 Bonding PDMS and glass slide  
16 Curing device for 20min in 80C̊ oven. 
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TABLE A-3 
The age dependency of the composition of urine in the healthy women 
(mmol/24h) [41] 
Age group  20's 40's 60's  
Parameter 
Volume (ml) 1277 1261 886 
pH 6.27 6.14 5.89 
Titratable acid 19.66 25.52 21.64 
Ammonium 32.36 37.15 30.74 
Sodium 148.3 153 78.6 
Potassium 43.26 54.36 37.07 
Calcium 3.54 4.41 1.8 
Magnesium 5.41 4.08 2.98 
Chloride 123.9 133.1 70.4 
Phosphorus 22.64 21.2 14.19 
Sulfate 18.79 20.01 10.59 
Uric acid 3.04 3.07 1.94 
Oxalic acid 0.353 0.376 0.299 
Citric acid 2.06 1.94 1.33 
Creatinine 10.56 11.5 6.94 
Ionic strength (mol/l) 0.208 0.218 0.186 
Ionic calcium 1.58 2.2 1.17 
Relative super-
saturation 5.67 7.18 5.9 
 
